Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

SALE OF NON-MARKETABLE SECURITIES

v3.22.4
SALE OF NON-MARKETABLE SECURITIES
12 Months Ended
Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]  
SALE OF NON-MARKETABLE SECURITIES
NOTE 15:-
SALE OF NON-MARKETABLE SECURITIES
 
In November 2021, the Company sold its equity investment in a privately held company with no readily determinable fair value which was accounted for under the measurement alternative pursuant to ASC 320, for $2,178. The Company recognized a profit in the amount of $2,012 in financial income, net.